$2.29
+0.00 (+0.00%)
Open$2.32
Previous Close$2.29
Day High$2.35
Day Low$2.27
52W High$7.40
52W Low$2.10
Volume—
Avg Volume59.5K
Market Cap36.50M
P/E Ratio—
EPS$-1.20
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,536.7% upside
Current
$2.29
$2.29
Target
$37.48
$37.48
$21.76
$37.48 avg
$51.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.87M | 30.53M | 6.59M |
| Net Income | -44,473,365 | -61,502,809 | 1.64M |
| Profit Margin | -223.9% | -212.7% | 24.9% |
| EBITDA | -42,308,964 | -61,760,165 | 3.19M |
| Free Cash Flow | — | — | 1.30M |
| Rev Growth | -34.9% | -34.9% | +19.2% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |